Engineering cocrystals of paliperidone with enhanced solubility and dissolution characteristics
In the present study, co-crystals (CCs) of Paliperidone (PPD) with coformers like benzoic acid (BA) and P-amino benzoic acid (PABA) were synthesized and characterized to improve the physicochemical properties and dissolution rate. CCs were prepared by the solvent evaporation (SE) technique and were compared with the products formed by neat grinding (NG) and liquid assisted grinding (LAG) in their enhancement of solubility. The formation of CCs was confirmed by the IR spectroscopy, powder X-ray diffraction and thermal analysis methods. The saturation solubility studies indicate that the aqueous solubility of PPD-BA and PPD-PABA CCs was significantly improved to 1.343±0.162mg/ml and 1.964±0.452mg/ml, respectively, in comparison with the PPD solubility of 0.473mg/ml. This increase in solubility is 2.83- and 3.09- fold, respectively. PPD exhibited a poor dissolution of 37.8% in 60min, while the dissolution of the CCs improved tremendously to 96.07% and 89.65% in 60min. CCs of PPD with BA and PABA present a novel approach to overcome the solubility challenges of poorly water-soluble drug PPD.
Dolores RS, David W, Peter OC, Naila AM, Zelalem AW, Fransico BF et al. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray drying. European Journal of Pharmaceutics and Biopharmaceutics. 2018;124:13-27.
Blagden N, Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced Drug Delivery Reviews. 2007;59:617-630.
Abigail A, Jean RA, Pascal B, Harvey L. Modelling and prediction of cocrystal phase diagrams. International Journal of Pharmaceutics. 2009;374:82-89.
Changyan G, Haobin Z, Xiaochuan W, Jinjiang X, Yu L, Xiaofeng L et al. Crystal structure and explosive performance of a new CL-20/caprolactam cocrystal. Journal of Molecular Structure. 2013;1048:267-273.
Ning Q, Mingzhong L, Walkiria S, Naznee M, Angela D, Gary T. Pharmaceutical cocrystals: An overview. 2011;419:1-11.
Elena IK, Kratochvil B. Pharmaceutical cocrystals. Procedia Chemistry. 2014;10:473-476.
Dhara DB, Chetan HB. Spring and parachute: How cocrystals enhance solubility. Progress in Crystal Growth and Characterization of Materials. 2016;62:1-8.
Mohammad AM, Amjad A, Sitaram PV. Hansen solubility parameter as a tool to predict cocrystal formation. International Journal of Pharmaceutics. 2011;407:63-71.
Marisa R, Barbara B, Joao AL, Mafalda CS. Pharmaceutical cocrystallization techniques. Advances and challenges. International Journal of Pharmaceutics. 2018;547:404-420.
Gagniere E, Mangin D, Puel F, Rivoire A, Monnier O, Garcia E, Klein JP. Formation of co-crystals: Kinetic and thermodynamic aspects. Journal of Crystal Growth. 2009;311:2689-2695.
Rajesh T, Dinesh K, Rahul RC, Nalini RS. Multidrug co-crystals: towards the development of effective therapeutic hybrids. Drug Discovery Today. 2016;21(3):481-490.
Swetha K, Raju J, Prabhakar RV, Suresh B. Paliperidone loaded self-emulsifying drug delivery systems (SEDDS) for improved oral delivery. Journal of Dispersion Science and Technology. 2012;33:506-515.
Raj KM, Surendra G. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of paliperidone using different hydrophilic carriers: In vitro in vivo study. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(4):393-408.
Anuja P, Bhabagrahi R, Anil KD. Dissolution rate and bioavailability enhancement of co-ground mixtures of paliperidone, with different hydrophilic carriers. International Current Pharmaceutical Journal. 2013;2(3):70-77.
Prabhakar D, Divya A, Pratyusha R, Shravan KK. Augmentation of dissolution profile of poorly soluble paliperidone by employing liquisolid technology. International Journal of PharmTech Research. 2014;6(2):710-719.
Sameer HL, Mangesh RB. Properties of solid dispersions of paliperidone in polyethylene glycol, comparison of solid-state properties, implementation of factorial design and dissolution behaviour. International Journal of Pharmacy and Biological Sciences. 2014;4(4):90-99.
Pandey A, Rath B, Dwivedi AK. Dissolution rate enhancement of BCS class II drug, Paliperidone by spray drying. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2013;4(2):145- 155.
Pandey A, Rath B, Dwivedi AK. Enhancement of dissolution rate and bioavailability of paliperidone by hot melt extrusion technique. Journal of Scientific & Industrial Research. 2014;73:680-685.
Thimmasetty J, Ghosh T, Shashank NN, Raheem A. Oral bioavailability enhancement of Paliperidone by the use of cocrystallization and precipitation inhibition. Journal of Pharmaceutical Innovation. 2021;16(2):160-169.
Pawar A, Paradkar AR, Kadam SS, Mahadik KR. Effect of polymers on crystallo-co-agglomeration of Ibuprofen-Paracetamol: Factorial design. Indian Journal of Pharmaceutical Sciences. 2007;69(5):658-664.
Tingting Z, Yan Y, Xiaojun Z, Jiangtao J, Hongmin S, Hongming H et al. Dissolution and pharmacokinetic properties of two paliperidone cocrystals with 4-hydroxybenzoic acid and 4-amino benzoic acid. CrystEngComm. 2014;16:7667-7672.
David RW, Tanise S, Peddy V, Michael Z. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: Mechanochemistry vs slow evaporation from solution. Crystal Growth & Design. 2009;9(2):1106-1123.
Sawani GK, Sunil KJ, Abhay TS, Sadhika K, Sanjay KM. Multicomponent pharmaceutical adducts of eposartan: physicochemical properties and pharmacokinetics study. Crystal Growth and Design. 2017;17(4):1589-1599.
Anand A, Paul R, Amolkumar K, Ravindra H. Formulation and evaluation of buccal films of piroxicam co-crystals. Future Journal of Pharmaceutical Sciences. 2020;6:16.
Radha RE, Bharathi VV, Lakshmi UA, Bhavani AVS. Cross-linked chitosan based stomach specific mucoadhesive microspheres loaded with amoxicillin: Preparation and ex vivo characterization. Int. J. Pharm. Investigation. 2020;10(1):59-63.
Amjad A, Waseem K, Graham B, Hardyal G, Ali N, Sitaram PV. Theophylline cocrystals prepared by spray drying: Physicochemical properties and aerosolization performance. AAPS PharmSciTech. 2013;14(1):265-276.
Cecilia CP, Cristiane CM, Matheus SS, Luan FD, Renato JE. 5- fluorocytosine/5- fluorouracil drug-drug cocrystal: a new development route based on mechanical synthesis. Journal of Pharmaceutical Innovation. 2019;14:50-56.
Miranda LC, David RW, Ning S, Mazen H, Lukasz W, Michael JZ. Coformer selection in pharmaceutical cocrystal development: a case study of a Meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics. Journal of Pharmaceutical Sciences. 2011;100(6):2172-2181.
Ravindra SD, Shailesh VB, Anant RP, Peter Y. Ultrasound assisted engineering of lactose crystals. Pharmaceutical Research. 2008;25(12):2835-2844.
Kevin CG, Jaydeep MP, Anjali PD, Abhay TD. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: An integrated approach of principal component analysis and Box-Behnken experimental design. International Journal of Pharmaceutics. 2013;452:135-156.
Prabhakar P, Giridhar S, Sarfaraj S, Pavan BR. Pharmaceutical Cocrystal of Piroxicam: Design, formulation and evaluation. Adv Pharm Bull. 2017;7(3):399-408.
Gaikwad ER, Khabade SS, Sutar TB, Santosh AP. Preparation and characterization of molecular complexes of fenofibrate cocrystal. Asian Journal of Pharmaceutics. 2017;11(4):745-759.
Prabhakar P, Giridhar S. Design and preparation of Zaltoprofen-Nicotinamide pharmaceutical cocrystals via liquid assisted grinding method. Indian Journal of Pharmaceutical Education and Research. 2019;54(4):563-570.
Ravindra SD, Adrian LK, Peter Y, Phil DC, Anant P. Cocrystallization and simultaneous agglomeration using melt extrusion. Pharmaceutical Research. 2010;27:2725-2733.
Santosh SC, Yatish RR, Anjali BT, Jaiprakash NS, Debarshi KM, Sanjay JK. Solvent drop grinding approach assisted development of glimepiride co-crystals: solubility enhancement journey of BCS class II product. Indian Journal of Pharmaceutical Education and Research. 2020;54(3):602-609.
Apurva JM, Grishma MP, Pragna KS, Anita NL. Development and characterization of thermosensitive intranasal gel containing paliperidone loaded microspheres. J Young Pharm. 2016;8(4):368-377.
Garbacz P, Wesolowski M. Benzodiazepine co-crystals screening using FTIR and Raman spectroscopy supported by differential scanning calorimetry. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2020;234:118242.
Xiaohong P, Yilin Z, Rong Ch, Saif Q, Zhi Ch, Wenhua R et al. Cocrystal of sulfamethazine and p-amino benzoic acid: structural establishment and enhanced antibacterial properties. Cryst. Growth Des. 2019;19:2455-2460.
Palash S, Rajesh GN, Khandavilli UBR, Ashwini N. Fast dissolving curcumin cocrystals, Crystal Growth & Design. 2011;11:4135- 4145.
Braham D, Manjusha Ch, Vikas B. Preparation, characterization and evaluation of aspirin: benzoic acid cocrystals with enhanced pharmaceutical properties. Future Journal of Pharmaceutical Sciences. 2020;6:32.
Raju RT, Patond VB, Vaibhav SA, Prashant VA, Laxmikant NB, Nilesh MM et al. Preparation and characterization of co-crystals of diacerein. Indonesian J Pharm. 28(1):34-41.
Napada W, Manop Ch. Application of Box-Behnken design for processing of mefenamic acid-paracetamol cocrystals using gas anti-solvent process. Journal of CO2 utilization. 2018;26:212-220.
Rehem AK, Yacoub AB, Aly N. Dissolution enhancement of atorvastatin calcium by cocrystallization. Advanced Pharmaceutical Bulletin. 2019;9(4):559-570.
Fang L, Ling YW, Ming CY, Yan TL, Zhi YW, Cui WY. A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure and in vitro/ in vivo performance evaluation. European Journal of Pharmaceutical Sciences. 2020;144:105216.
Madhukar H, Wan SL, Ching KQ, Hoong KF. Investigation of supramolecular synthons and structural characterization of aminopyridine-carboxylic acid derivatives. Chemistry Central Journal. 2014;8:31.
Jianle Z, Liang L, Hailu Z, Jiangping X, Dandan H, Ningbo G et al. Crystal structures, dissolution and pharmacokinetic study on novel phosphodiesterase-4 inhibitor chlorbipram cocrystals. International Journal of Pharmaceutics. 2020;576:118984.
Anastasiya VM, Svetlana AM, Natalia VB, Konstantin BG, Svetlana AK, Tatyana PS. Screening and characterization of cocrystal formation between botulin and terephthalic acid. Materials Today: Proceedings. 2020;25(3):381-383.
Amol S, Srinivasa M, Bhagyashri T, Adhikrao Y, Sachin S, Sfurti S, Rajendra D. Studies on effect of hydrophilic polymers on physicochemical properties of itraconazole cocrystals. Future Journal of Pharmaceutical sciences. 2017;3:95-102.
Perlovich GL, Manin AN. Design of pharmaceutical cocrystals for drug solubility improvement. Russian Journal of General Chemistry. 2014;84(2): 407-414.